[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Report 2017

January 2018 | 116 pages | ID: A9413B46289EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Klebsiella Pneumoniae Infection Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Klebsiella Pneumoniae Infection Drug for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Klebsiella Pneumoniae Infection Drug market competition by top manufacturers/players, with Klebsiella Pneumoniae Infection Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Acies Bio doo
  • Appili Therapeutics
  • Debiopharm International SA
  • Evaxion Biotech ApS
  • F. Hoffmann-La Roche Ltd
  • FOB Synthesis Inc
  • ImmunoClin Corp
  • Innovation Pharmaceuticals Inc
  • Kyorin Pharmaceutical Co Ltd
  • Melinta Therapeutics Inc
  • Nosopharm SAS
  • Peptilogics Inc
  • Pfizer Inc
  • Phico Therapeutics Ltd
  • Sarepta Therapeutics Inc
  • Shionogi & Co Ltd
  • Syntiron LLC
  • Tetraphase Pharmaceuticals Inc
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • ATI-1503
  • CA-824
  • CC-1807
  • Cefiderocol
  • Debio-1454
  • EBX-004
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Report 2017

1 KLEBSIELLA PNEUMONIAE INFECTION DRUG OVERVIEW

1.1 Product Overview and Scope of Klebsiella Pneumoniae Infection Drug
1.2 Classification of Klebsiella Pneumoniae Infection Drug by Product Category
  1.2.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 ATI-1503
  1.2.4 CA-824
  1.2.5 CC-1807
  1.2.6 Cefiderocol
  1.2.7 Debio-1454
  1.2.8 EBX-004
  1.2.9 Others
1.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Market by Application/End Users
  1.3.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Asia-Pacific Klebsiella Pneumoniae Infection Drug Market by Region
  1.4.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Klebsiella Pneumoniae Infection Drug (2012-2022)
  1.5.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug (Volume) by Application
2.4 Asia-Pacific Klebsiella Pneumoniae Infection Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Region (2012-2017)

3 CHINA KLEBSIELLA PNEUMONIAE INFECTION DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Klebsiella Pneumoniae Infection Drug Sales and Value (2012-2017)
  3.1.1 China Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Klebsiella Pneumoniae Infection Drug Sales Price Trend (2012-2017)
3.2 China Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Type
3.3 China Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Application

4 JAPAN KLEBSIELLA PNEUMONIAE INFECTION DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Klebsiella Pneumoniae Infection Drug Sales and Value (2012-2017)
  4.1.1 Japan Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Klebsiella Pneumoniae Infection Drug Sales Price Trend (2012-2017)
4.2 Japan Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Type
4.3 Japan Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Application

5 SOUTH KOREA KLEBSIELLA PNEUMONIAE INFECTION DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Klebsiella Pneumoniae Infection Drug Sales and Value (2012-2017)
  5.1.1 South Korea Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Klebsiella Pneumoniae Infection Drug Sales Price Trend (2012-2017)
5.2 South Korea Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Type
5.3 South Korea Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Application

6 TAIWAN KLEBSIELLA PNEUMONIAE INFECTION DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Klebsiella Pneumoniae Infection Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Klebsiella Pneumoniae Infection Drug Sales Price Trend (2012-2017)
6.2 Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Type
6.3 Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Application

7 INDIA KLEBSIELLA PNEUMONIAE INFECTION DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Klebsiella Pneumoniae Infection Drug Sales and Value (2012-2017)
  7.1.1 India Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Klebsiella Pneumoniae Infection Drug Sales Price Trend (2012-2017)
7.2 India Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Type
7.3 India Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA KLEBSIELLA PNEUMONIAE INFECTION DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Application

9 AUSTRALIA KLEBSIELLA PNEUMONIAE INFECTION DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Klebsiella Pneumoniae Infection Drug Sales and Value (2012-2017)
  9.1.1 Australia Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Klebsiella Pneumoniae Infection Drug Sales Price Trend (2012-2017)
9.2 Australia Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Type
9.3 Australia Klebsiella Pneumoniae Infection Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Acies Bio doo
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Appili Therapeutics
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Debiopharm International SA
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Evaxion Biotech ApS
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 F. Hoffmann-La Roche Ltd
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 FOB Synthesis Inc
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 ImmunoClin Corp
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Innovation Pharmaceuticals Inc
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Kyorin Pharmaceutical Co Ltd
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Melinta Therapeutics Inc
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Nosopharm SAS
10.12 Peptilogics Inc
10.13 Pfizer Inc
10.14 Phico Therapeutics Ltd
10.15 Sarepta Therapeutics Inc
10.16 Shionogi & Co Ltd
10.17 Syntiron LLC
10.18 Tetraphase Pharmaceuticals Inc

11 KLEBSIELLA PNEUMONIAE INFECTION DRUG MANUFACTURING COST ANALYSIS

11.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC KLEBSIELLA PNEUMONIAE INFECTION DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Klebsiella Pneumoniae Infection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Klebsiella Pneumoniae Infection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Klebsiella Pneumoniae Infection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Klebsiella Pneumoniae Infection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Klebsiella Pneumoniae Infection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Klebsiella Pneumoniae Infection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Klebsiella Pneumoniae Infection Drug
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure ATI-1503 Product Picture
Figure CA-824 Product Picture
Figure CC-1807 Product Picture
Figure Cefiderocol Product Picture
Figure Debio-1454 Product Picture
Figure EBX-004 Product Picture
Figure Others Product Picture
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Klebsiella Pneumoniae Infection Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Size (Million USD) by Region (2012-2022)
Figure China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Share by Players
Figure 2017 Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Share by Players
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Klebsiella Pneumoniae Infection Drug by Type (2012-2017)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Klebsiella Pneumoniae Infection Drug by Type (2012-2017)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Klebsiella Pneumoniae Infection Drug by Region (2012-2017)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share by Region in 2016
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Klebsiella Pneumoniae Infection Drug by Region (2012-2017)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type in 2016
Table China Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application in 2016
Figure Japan Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type in 2016
Table Japan Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application in 2016
Figure South Korea Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type in 2016
Table South Korea Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type in 2016
Table Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application in 2016
Figure India Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2012-2017)
Figure India Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type in 2016
Table India Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2012-2017)
Figure India Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application in 2016
Figure Australia Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Klebsiella Pneumoniae Infection Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type in 2016
Table Australia Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application in 2016
Table Acies Bio doo Klebsiella Pneumoniae Infection Drug Basic Information List
Table Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Appili Therapeutics Klebsiella Pneumoniae Infection Drug Basic Information List
Table Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Debiopharm International SA Klebsiella Pneumoniae Infection Drug Basic Information List
Table Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Basic Information List
Table Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Basic Information List
Table F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Basic Information List
Table ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Basic Information List
Table Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Nosopharm SAS Klebsiella Pneumoniae Infection Drug Basic Information List
Table Peptilogics Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Pfizer Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Basic Information List
Table Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Basic Information List
Table Syntiron LLC Klebsiella Pneumoniae Infection Drug Basic Information List
Table Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Klebsiella Pneumoniae Infection Drug
Figure Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
Figure Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
Table Raw Materials Sources of Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
Table Major Buyers of Klebsiella Pneumoniae Infection Drug
Table Distributors/Traders List
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Region in 2022
Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories